New Wave Biotech, a company specializing in AI-driven bioprocess simulation software, has raised €1.2 million in a new funding round. The investment, which includes contributions from Innovate UK and ...

Orbillion has achieved a notable step in the cultivated meat sector, announcing the production of its beef muscle cells at manufacturing facilities in North America, Europe, and Asia. The expansion ...

Finnish-American food ingredient company Onego Bio has submitted a Generally Recognized as Safe (GRAS) notification to the U.S. Food and Drug Administration (FDA) for its animal-free ovalbumin.

The international business webtalk series ‘update’ discusses the most pressing issues of the ongoing protein transition. Based on the latest news, data, and facts, the future of the industry will be ...

In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding alt proteins in 2024 and uncovers the investment playbooks of successful climate tech CEOs and leading VCs.

Atlantic Natural Foods (ANF), the manufacturer of shelf-stable plant-based brands Loma Linda®, neat™, and TUNO™, has withdrawn from an agreement that would have seen it acquired by vertically ...

A new study conducted by nonprofit organization Faunalytics aims to shed light on the way veganism can spread through a social network. To determine the influence of peers on socially influenced ...

A new study conducted by nonprofit organization Faunalytics aims to shed light on the way veganism can spread through a social network. To determine the influence of peers on socially influenced ...

As another year draws to a close, it is challenging to encapsulate the past months in just a few words. 2024 has undoubtedly been a year filled with challenges. The economic climate—marked by ...

Atlantic Natural Foods (ANF), the manufacturer of shelf-stable plant-based brands Loma Linda®, neat™, and TUNO™, has withdrawn from an agreement that would have seen it acquired by vertically ...

In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding alt proteins in 2024 and uncovers the investment playbooks of successful climate tech CEOs and leading VCs.